UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

The extracellular domain of Her2 in serum as a biomarker of breast cancer

Laboratory investigation, 2018-06, Vol.98 (6), p.696-707

2018

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6587

2021

Link zum Volltext

Verfügbarkeit prüfen

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Journal of translational medicine, 2010-07, Vol.8 (1), p.71-71, Article 71

2010

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Pharmacology of the Taxanes: Implications of the Differences

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (S2), p.3-8

2004

Link zum Volltext

Verfügbarkeit prüfen

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial

The lancet oncology, 2014-11, Vol.15 (12), p.1351-1360

2014

Link zum Volltext

Verfügbarkeit prüfen

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

The lancet oncology, 2013-09, Vol.14 (10), p.962-970

2013

Link zum Volltext

Verfügbarkeit prüfen

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

PloS one, 2020-01, Vol.15 (1), p.e0227356-e0227356

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

The lancet oncology, 2012-04, Vol.13 (4), p.375-384

2012

Link zum Volltext

Verfügbarkeit prüfen

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Health and quality of life outcomes, 2023-01, Vol.21 (1), p.11-11, Article 11

2023

Link zum Volltext

Verfügbarkeit prüfen

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes

Frontiers in oncology, 2018-04, Vol.8, p.112-112

2018

Link zum Volltext

Verfügbarkeit prüfen

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

Breast (Edinburgh), 2022-12, Vol.66, p.145-156

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

BMJ open, 2022-09, Vol.12 (9), p.e061664

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study

Breast (Edinburgh), 2022-08, Vol.64, p.151-158

2022

Link zum Volltext

Verfügbarkeit prüfen

Early HER2-positive breast cancers: time for a new revolution?

The lancet oncology, 2018-01, Vol.19 (1), p.12-13

Gligorov, Joseph

2018

Link zum Volltext

Verfügbarkeit prüfen

Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence

Cancers, 2023-04, Vol.15 (8), p.2278

2023

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab and trastuzumab: the rationale way to synergy

Anais da Academia Brasileira de Ciências, 2016-01, Vol.88 Suppl 1 (suppl 1), p.565-577

2016

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

European journal of breast health, 2020-07, Vol.16 (3), p.160-161

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network

Breast (Edinburgh), 2022-02, Vol.61, p.168-174

2022

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Cardiovascular and interventional radiology, 2019-12, Vol.42 (12), p.1806-1809

2019

Link zum Volltext

Verfügbarkeit prüfen

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Heliyon, 2023-11, Vol.9 (11), p.e22180-e22180, Article e22180

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network

Breast (Edinburgh), 2020-12, Vol.54, p.311-318

2020

Link zum Volltext

Verfügbarkeit prüfen

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy

Cancer cell international, 2018-11, Vol.18 (1), p.175-175, Article 175

2018

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy for early-stage breast cancer: learning from the past to build the future

Nature reviews. Clinical oncology, 2022-12, Vol.19 (12), p.763-774

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study

Cancers, 2021-09, Vol.13 (19), p.4749

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(244)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(152)
Life Sciences & Biomedicine
(148)
Humans
(132)
Oncology
(124)
Female
(100)
Breast Cancer
(74)
Breast Neoplasms - Drug Therapy
(57)
Cancer
(52)
Life Sciences
(45)
Middle Aged
(43)
Breast Neoplasms - Pathology
(42)
Adult
(41)
Aged
(41)
Chemotherapy
(41)
Tumors
(31)
Prognosis
(30)
Trastuzumab
(30)
Hematology, Oncology And Palliative Medicine
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Antineoplastic Agents - Therapeutic Use
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bulletin Du Cancer
(61)
Journal Of Clinical Oncology
(25)
Breast
(16)
Cancer Research
(15)
Oncologie
(13)
The Journal Of High Energy Physics
(8)
Breast Cancer Research And Treatment
(7)
Critical Reviews In Oncology/hematology
(7)
Cancer
(6)
The Lancet Oncology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The extracellular domain of Her2 in serum as a biomarker of breast cancer

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Preclinical Pharmacology of the Taxanes: Implications of the Differences

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study

Early HER2-positive breast cancers: time for a new revolution?

Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence

Pertuzumab and trastuzumab: the rationale way to synergy

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy

Systemic therapy for early-stage breast cancer: learning from the past to build the future

Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study

Suchergebnisse filtern